These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 1703341)

  • 1. Correlation between bioassayed plasma levels of FK 506 and lymphocyte growth from liver transplant biopsies with histological evidence of rejection.
    Zeevi A; Eiras G; Kaufman C; Alessiani M; Demetris AJ; Abu-Elmagd K; Jain A; Warty V; Venkataramanan R; Burckart G
    Transplant Proc; 1991 Feb; 23(1 Pt 2):1406-8. PubMed ID: 1703341
    [No Abstract]   [Full Text] [Related]  

  • 2. Bioassay of plasma specimens from liver transplant patients on FK 506 immunosuppression.
    Zeevi A; Eiras G; Burckart G; Jain A; Kragack A; Venkataramanan R; Todo S; Fung J; Starzl TE; Duquesnoy RJ
    Transplant Proc; 1990 Feb; 22(1):60-3. PubMed ID: 1689902
    [No Abstract]   [Full Text] [Related]  

  • 3. Pathologic observations in human allograft recipients treated with FK 506.
    Demetris AJ; Fung JJ; Todo S; Banner B; Zerbe T; Sysyn G; Starzl TE
    Transplant Proc; 1990 Feb; 22(1):25-34. PubMed ID: 1689891
    [No Abstract]   [Full Text] [Related]  

  • 4. Study of the correlation between MEIA and ELISA methods for FK 506 determination in liver transplant recipients.
    Rudant E; Bezie Y; Bonhomme-Faivre L; Manuel N; Rucay P; Fredj G; Bismuth H
    J Clin Pharm Ther; 1997 Apr; 22(2):135-40. PubMed ID: 9373812
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tacrolimus (FK 506) for rescue of chronic rejection following orthotopic liver transplantation.
    Sher LS; Cosenza CA; Petrovic LM; Rojter S; Hoffman A; Lopez RR; Meehan M; Pan SH; Vierling J; Makowka L
    Transplant Proc; 1996 Apr; 28(2):1011-3. PubMed ID: 8623212
    [No Abstract]   [Full Text] [Related]  

  • 6. FK 506 therapy for refractory renal allograft rejection: lessons from liver transplantation.
    Woodle ES; Bruce DS; Josephson M; Newell KA; Piper JB; Millis JM; Cronin D; Whitman G; Ruebe M; Thistlethwaite JR
    Clin Transplant; 1996 Aug; 10(4):323-32. PubMed ID: 8884103
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Positive crossmatch in primary human liver allografts under cyclosporine or FK 506 therapy.
    Takaya S; Duquesnoy R; Iwaki Y; Demetris J; Yagihashi A; Bronsther O; Iwatsuki S; Starzl TE
    Transplant Proc; 1991 Feb; 23(1 Pt 1):396-9. PubMed ID: 1703691
    [No Abstract]   [Full Text] [Related]  

  • 8. Comparative analysis of tacrolimus (FK506) in whole blood liver transplant recipients by PRO-TRAC enzyme-linked immunosorbent assay and microparticle enzyme immunoassay IMX methods.
    Brunet M; Pou L; Torra M; López R; Rodamilans M; Corbella J
    Ther Drug Monit; 1996 Dec; 18(6):706-9. PubMed ID: 8946669
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of the Pro-Trac tacrolimus monoclonal whole-blood enzyme-linked immunosorbent assay for monitoring of tacrolimus levels in patients after kidney, heart, and liver transplantation.
    Winkler M; Christians U; Baumann J; Gonschior AK; Wonigeit K; Pichlmayr R
    Ther Drug Monit; 1996 Dec; 18(6):640-6. PubMed ID: 8946659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of immunosuppressive monotherapy in liver transplantation: tacrolimus versus microemulsified cyclosporin.
    Rolles K; Davidson BR; Burroughs AK
    Transplantation; 1999 Oct; 68(8):1195-8. PubMed ID: 10551650
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synergistic effects of Isatis tinctoria L. and tacrolimus in the prevention of acute heart rejection in mice.
    Wang Y; Qin Q; Chen J; Kuang X; Xia J; Xie B; Wang F; Liang H; Qi Z
    Transpl Immunol; 2009 Dec; 22(1-2):5-11. PubMed ID: 19766187
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of FK 506 in plasma lipoproteins in transplant patients.
    Warty V; Venkataramanan R; Zendehrouh P; McKaveney T; Chao J; Todo S; Starzl T
    Transplant Proc; 1991 Feb; 23(1 Pt 2):954-5. PubMed ID: 1703363
    [No Abstract]   [Full Text] [Related]  

  • 13. FK 506 rescue therapy in liver transplant recipients with drug-resistant rejection.
    Lewis WD; Jenkins RL; Burke PA; Winn KM; Shaffer D; Lopez R; Monaco AP
    Transplant Proc; 1991 Dec; 23(6):2989-91. PubMed ID: 1721336
    [No Abstract]   [Full Text] [Related]  

  • 14. TGF-beta expression in protocol transplant liver biopsies: a comparative study between cyclosporine-A (CyA) and tacrolimus (FK 506) immunosuppression.
    Mohamed MA; Burt AD; Robertson H; Kirby JA; Talbot D
    Transplant Proc; 2001; 33(1-2):1378-80. PubMed ID: 11267336
    [No Abstract]   [Full Text] [Related]  

  • 15. Propagation of lymphocytes infiltrating human liver allografts. Correlation with histologic diagnosis of rejection.
    Saidman SL; Demetris AJ; Zeevi A; Duquesnoy RJ
    Transplantation; 1990 Jan; 49(1):107-12. PubMed ID: 2301000
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elimination of FK-506 by continuous hemodiafiltration in a liver transplant patient.
    Tsubo T; Iwakawa T; Muraoka M; Ishihara H; Matsuki A
    ASAIO J; 1997; 43(4):363-4. PubMed ID: 9242954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Smooth muscle-specific actin levels in the urine of renal transplant recipients: correlation with cyclosporine or tacrolimus nephrotoxicity.
    Haas M; Meehan SM; Josephson MA; Wit EJ; Woodle ES; Thistlethwaite JR
    Am J Kidney Dis; 1999 Jul; 34(1):69-84. PubMed ID: 10401019
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Four-year follow-up of a prospective randomized trial of mycophenolate mofetil with cyclosporine microemulsion or tacrolimus following liver transplantation.
    Fisher RA; Stone JJ; Wolfe LG; Rodgers CM; Anderson ML; Sterling RK; Shiffman ML; Luketic VA; Contos MJ; Mills AS; Ferreira-Gonzalez A; Posner MP
    Clin Transplant; 2004 Aug; 18(4):463-72. PubMed ID: 15233827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of a new immunoassay for therapeutic drug monitoring of tacrolimus in adult liver transplant recipients.
    Marubashi S; Nagano H; Kobayashi S; Eguchi H; Takeda Y; Tanemura M; Umeshita K; Monden M; Doki Y; Mori M
    J Clin Pharmacol; 2010 Jun; 50(6):705-9. PubMed ID: 20097937
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diminished lymphocyte growth from endomyocardial biopsies from cardiac transplant patients on FK 506 immunosuppression.
    Chen-Woan M; Zerbe TR; Zeevi A; Kaufman C; Mallick C; Warty VJ; Griffith BP; Kormos RL; Armitage J; Duquesnoy RJ
    Transplant Proc; 1991 Dec; 23(6):2941-2. PubMed ID: 1721320
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.